跳至主要内容
临床试验/NCT04499898
NCT04499898招募中2 期

Randomized Controlled Trial of Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding in Cirrhotic Patients With Arterial Hypertension

Sherief Abd-Elsalam1 个研究点 分布在 1 个国家目标入组 306 人开始时间: 2018年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
306
试验地点
1
主要终点
Number of patients with the first variceal bleeding within 1 year

研究概览

简要总结

Carvedilol versus endoscopic band ligation for primary prophylaxis of oesophageal variceal bleeding in cirrhotic patients with arterial hypertension

详细描述

A Randomized controlled trial of carvedilol versus endoscopic band ligation for primary prophylaxis of oesophageal variceal bleeding in cirrhotic patients with arterial hypertension

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • • Aged >18 years
  • Cirrhotic patients with arterial hypertension
  • Endoscopic evidence of medium/large-sized esophageal varices

排除标准

  • • History of variceal bleeding or previous primary prevention of varices.
  • Portal vein thrombosis or previous porto-systemic shunts as TIPS.
  • Patients on drugs affecting portal pressure (beta blockers, nitrates).
  • Advanced cardiovascular disease including acute myocardial infarction, atrio-ventricular block, congestive heart failure, chronic peripheral ischemia, severe bradycardia.
  • Patients with severe respiratory diseases (COPD, bronchial asthma).
  • Uncontrolled diabetes mellitus
  • Renal impairment
  • Hepatocellular carcinoma
  • Allergy to carvedilol
  • Pregnancy or lactation

研究组 & 干预措施

carvedilol

Experimental

Carvedilol

干预措施: Carvedilol (Drug)

Band Ligation

Active Comparator

Band Ligation

干预措施: Endoscopic band ligation (Procedure)

结局指标

主要结局

Number of patients with the first variceal bleeding within 1 year

时间窗: 1 year

The number of patients with the first variceal bleeding within 1 year

次要结局

未报告次要终点

研究者

发起方
Sherief Abd-Elsalam
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Sherief Abd-Elsalam

Ass. Prof. Tropical Medicine

Tanta University

研究点 (1)

Loading locations...

相似试验